China Food and Drug Administration approved new vaccine to treat Poliomyelitis

Jan 16, 2015 16:36 IST

Chinese drug regulator China Food and Drug Administration (CFDA) on 15 January 2015 approved a new vaccine S-IPV to treat the Poliomyelitis.

The vaccine S-IPV is known as Ai Bi Wei in China. It is manufactured by the Institute of Medical Biology of the Chinese Academy of Medical Sciences located in Kunming, southwest China's Yunnan province.

The vaccine will be given to Chinese children as part of routine disease prevention and will help the global fight against the polio virus. The World Health Organisation is also considering use of this new vaccine in its global polio treatment program.

Background
Poliomyelitis is a highly contagious disease caused by the poliovirus, which attacks the nervous system and can cause lifelong paralysis or even death.

China technically eradicated polio in 2000, but there have been outbreaks of the disease in the country since then. In this case, the S-IPV is a breakthrough for China to keep the polio-free status.

Is this article important for exams ? Yes19 People Agreed

DISCLAIMER: JPL and its affiliates shall have no liability for any views, thoughts and comments expressed on this article.

Latest Videos

Register to get FREE updates

    All Fields Mandatory
  • (Ex:9123456789)
  • Please Select Your Interest
  • Please specify

  • ajax-loader
  • A verifcation code has been sent to
    your mobile number

    Please enter the verification code below

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK